New strategies and key mechanisms for hearing loss treatment , are you ready?

• Types and mechanisms of hearing loss
• New progress in gene therapy for hearing loss
• New progress in regenerative therapy for hearing loss
• Tracking of new drug candidates for hearing loss treatment
• Epidemiology of hearing loss and drug development status in China
• An innovative biotech roadshow

Event details

DATE Wed, Feb 26, 2025 VENUE Online Webex / Zoom TIME 8:00 – 9:00 Berlin time (CET) 15:00 – 16:00 Beijing time (GMT+8) RSVP This is a complimentary event VIP tickets priority for Lingmed current clients Please RSVP by Feb 26, 2025

PRESENTERS Lingling Cao, CEO & Founder Zhang Ran, Medical advisor REGISTER +86 21 5386 3003 info@lingmed.cn

Agenda

CET 8:00 - 8:30	New strategies and key mechanisms for hearing loss treatment	by Zhang Ran  (Chinese)
CET 8:30 - 8:35	Linkedbio services & projects introduction	by Lingling Cao  (English)
CET 8:35 - 8:55	An innovative biotech roadshow	by Guest speaker   (English)
CET 8:55 – 9:00	Q&A	(English & Chinese)

Presenters

Zhang Ran Medical advisor China Pharmaceutical University master HealthShare Management and Consulting Co., Ltd Co-founder 20 years of experience in new drug development. Engaged in new drug research and development in Yangtze River Pharmaceutical Group、Beijing Kawin Technology Share-Holding Co., Ltd.、Beijing Tri-Prime Gene Pharmaceutical Co., Ltd. Co-founded HealthShare in 2016. Serve a number of listed pharmaceutical enterprises. Mainly engaged in research and development pipeline strategic planning, new drug project evaluation, research and development management.

Lingling Cao CEO & Founder Lingling has more than a decade of experience in the healthcare industry, especially in deal-making. She founded Lingmed, which aims to support BD professionals to make better decisions with intelligence databases and EU-China cross-border deals. Prior to her venture at Lingmed, she was a senior BD manager for Eli Lilly in Shanghai and a consultant for McKinsey in Germany